BeStock  
Stocks › Biotechnology › RPRX

Royalty Pharma RPRX

US equityMarket cap rank #641Biotechnology
$68.45 +$0.73 (+1.08%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $67.91 -0.79%
Open$68.17
Prev close$67.72
Day range$67.95 – $68.83
Volume3.53M
Market cap$30.48B
P/E (TTM)44.7
Dividend yield1.35%

Analyst view

ConsensusBuy
Analysts6
Average target$72.67+6.2% vs. price
  • Buy 100%
Low $63.00Now $68.45Avg $72.67High $80.00

Recent rating changes

The last 20 actions on file set price targets from $62.00 to $80.00, averaging $68.37.

DateFirmRatingTarget
18 Nov 2026 TD Cowen BUY $80.00
5 Nov 2026 Morgan Stanley BUY $75.00
5 Nov 2026 Citi BUY $78.00
4 Nov 2026 J.P. Morgan BUY $74.00
12 Oct 2026 Citi BUY $70.00
9 Oct 2026 BofA Securities BUY $63.00
7 Oct 2026 Morgan Stanley BUY $67.00
23 Sep 2026 BofA Securities BUY $63.00
9 Sep 2026 Citi BUY $70.00
8 Sep 2026 TD Cowen BUY $68.00
8 Sep 2026 UBS BUY $66.00
11 Aug 2026 UBS BUY $66.00
10 Aug 2026 J.P. Morgan BUY $62.00
6 Aug 2026 Morgan Stanley BUY $65.00
6 Aug 2026 Citi BUY $70.00
6 Aug 2026 Goldman Sachs BUY $66.00
5 Aug 2026 Morgan Stanley BUY $65.00
15 Jul 2026 Citi BUY $66.00
13 Jul 2026 TD Cowen BUY $65.00
10 Jul 2026 BofA Securities BUY –

Discussion

No comments yet — be the first to weigh in on RPRX.

Sign in to join the discussion.

Scroll to Top